These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 895938)

  • 1. Host-tumor relationship. XXXIV. Hyaluronidase activity and hyaluronidase inhibitor in the serum of patients with malignant tumors.
    Koláŏvá M
    Neoplasma; 1977; 24(3):285-90. PubMed ID: 895938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Host-tumour relationship. XXX. A failure to demonstrate a special hyaluronidase inhibitor in the blood serum of cancer patients.
    Kolárová M
    Neoplasma; 1972; 19(5):547-51. PubMed ID: 4404914
    [No Abstract]   [Full Text] [Related]  

  • 3. Host-tumor relationship XXXIII. Inhibitor of hyaluronidase in blood serum of cancer patients.
    Kolárová M
    Neoplasma; 1975; 22(4):435-9. PubMed ID: 630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Host-tumour relationship. XXIX. Hyaluronidase activity and seromucoid concentration in blood serum of patients with cancer.
    Kolárová M; Tobiska J; Brada Z
    Neoplasma; 1970; 17(6):641-8. PubMed ID: 5534086
    [No Abstract]   [Full Text] [Related]  

  • 5. Difference of hyaluronidase produced by human tumor cell lines with hyaluronidase present in human serum as revealed by zymography.
    Podyma KA; Yamagata S; Sakata K; Yamagata T
    Biochem Biophys Res Commun; 1997 Dec; 241(2):446-52. PubMed ID: 9425290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Determination of superoxide dismutase (SOD) in serum of cancer patients by microchemical luminescence].
    Dai R
    Zhonghua Zhong Liu Za Zhi; 1989 Jul; 11(4):272-4. PubMed ID: 2625108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant serum hyaluronan and hyaluronidase levels in scleroderma.
    Neudecker BA; Stern R; Connolly MK
    Br J Dermatol; 2004 Mar; 150(3):469-76. PubMed ID: 15030329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The growth rate of two transplantable murine tumors, 3LL lung carcinoma and B16F10 melanoma, is influenced by Hyal-1, a locus determining hyaluronidase levels and polymorphism.
    De Maeyer E; De Maeyer-Guignard J
    Int J Cancer; 1992 Jun; 51(4):657-60. PubMed ID: 1601526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced activity of serum and urinary hyaluronidases in streptozotocin-induced diabetic Wistar and GK rats.
    Ikegami-Kawai M; Okuda R; Nemoto T; Inada N; Takahashi T
    Glycobiology; 2004 Jan; 14(1):65-72. PubMed ID: 14551218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Enzyme activity of peripheral blood granulocytes in patients with malignant neoplasms].
    Solov'eva EA; Zuborkhina GN; Kushnareva NI; Protasova AK
    Vopr Onkol; 1973; 19(6):22-5. PubMed ID: 4591594
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparative study of ribonucleotide reductase activities in normal and neoplastic human tissue.
    Gordon HL; Bardos TJ; Ambrus JL
    Res Commun Chem Pathol Pharmacol; 1970 Nov; 1(6):749-56. PubMed ID: 5524275
    [No Abstract]   [Full Text] [Related]  

  • 12. High uridine phosphorylase activity in human melanoma tumor.
    Leyva A; Kraal I; Lankelma J; Delemarre JF; Pinedo HM
    Anticancer Res; 1983; 3(4):227-31. PubMed ID: 6881921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purification and characterization of human serum hyaluronidase.
    Afify AM; Stern M; Guntenhöner M; Stern R
    Arch Biochem Biophys; 1993 Sep; 305(2):434-41. PubMed ID: 8373180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The effect of an insufficiency and an excess of thyroid hormones in the rabbit organism on the activity of a nonspecific inhibitor or hyaluronidase].
    Fogel PI
    Biull Eksp Biol Med; 1966 May; 61(5):51-3. PubMed ID: 4178224
    [No Abstract]   [Full Text] [Related]  

  • 15. Serum hyaluronidase levels in patients with aneurysmal subarachnoid haemorrhage.
    Isman F; Kucur M; Tanriverdi T; Kacira T; Sanus GZ; Kemerdere R; Hanimoglu H; Kaynar MY
    Singapore Med J; 2008 May; 49(5):405-9. PubMed ID: 18465052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased hyaluronidase levels in breast tumor metastases.
    Bertrand P; Girard N; Duval C; d'Anjou J; Chauzy C; Ménard JF; Delpech B
    Int J Cancer; 1997 Nov; 73(3):327-31. PubMed ID: 9359477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Gamma GT in the diagnosis of primary and secondary hepatic neoplasms].
    Lanfranco G; Gino GC; Bumma C; de Fillippi PG; Calciati A; Scuro S; La Grotta G; Bossi E
    Cancro; 1974; 27(4):205-19. PubMed ID: 4154805
    [No Abstract]   [Full Text] [Related]  

  • 18. Indomethacin as inhibitor of hyaluronidase.
    Szary A; Kowalczyk-Bronisz SH; Gieldanowski J
    Arch Immunol Ther Exp (Warsz); 1975; 23(1):131-4. PubMed ID: 1115580
    [No Abstract]   [Full Text] [Related]  

  • 19. [Determination of serum hyaluronidase activity in the combined presence of hyaluronidase, beta-glucuronidase and N-acetyl-beta-D-glucosaminidase].
    Vikha IV; Privalenko MN; Khorlin AIa
    Vopr Med Khim; 1973; 19(1):90-6. PubMed ID: 4545043
    [No Abstract]   [Full Text] [Related]  

  • 20. Nitric oxide synthase expression and enzymatic activity in human brain tumors.
    Broholm H; Rubin I; Kruse A; Braendstrup O; Schmidt K; Skriver EB; Lauritzen M
    Clin Neuropathol; 2003; 22(6):273-81. PubMed ID: 14672505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.